[卡维地洛与血管紧张素转换酶抑制剂重塑轻度心力衰竭评估试验] - Suppr | 超能文献

[The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].

作者信息

Shimamoto Ken, Kawana Masatoshi

机构信息

Ken Shimamoto, Department of Cardiology, Aoyama Hospital Tokyo Women's Medical University.

出版信息

Nihon Rinsho. 2007 Apr 28;65 Suppl 4:531-6.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial].[卡维地洛与血管紧张素转换酶抑制剂重塑轻度心力衰竭评估试验]

Nihon Rinsho. 2007 Apr 28;65 Suppl 4:531-6.

2

The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN).卡维地洛与血管紧张素转换酶抑制剂早期联合治疗轻度心力衰竭和左心室收缩功能障碍的益处。卡维地洛与血管紧张素转换酶抑制剂重塑轻度心力衰竭评估试验（CARMEN）。

Cardiovasc Drugs Ther. 2004 Jan;18(1):57-66. doi: 10.1023/B:CARD.0000025756.32499.6f.

3

Tolerability of carvedilol and ACE-Inhibition in mild heart failure. Results of CARMEN (Carvedilol ACE-Inhibitor Remodelling Mild CHF EvaluatioN).卡维地洛与血管紧张素转换酶抑制剂在轻度心力衰竭中的耐受性。卡门研究（卡维地洛血管紧张素转换酶抑制剂重塑轻度慢性心力衰竭评估）结果

Eur J Heart Fail. 2004 Jun;6(4):467-75. doi: 10.1016/j.ejheart.2003.12.019.

4

[Beta blockers and ACE inhibitors In heart failure to be combined at the beginning!].[β受体阻滞剂与血管紧张素转换酶抑制剂在心力衰竭治疗中应早期联合使用！]

MMW Fortschr Med. 2002 Nov 7;144(45):58.

5

The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure EvaluatioN trial (CARMEN)--rationale and design.卡维地洛与血管紧张素转换酶抑制剂重塑轻度心力衰竭评估试验（CARMEN）——原理与设计

Cardiovasc Drugs Ther. 2001 Jan;15(1):69-77. doi: 10.1023/a:1011166919718.

6

Impact of carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function.

J Am Coll Cardiol. 2005 Jul 5;46(1):181-2; author reply 183. doi: 10.1016/j.jacc.2005.04.010.

7

Beta blockers or angiotensin-converting-enzyme inhibitor/angiotensin receptor blocker: what should be first?β受体阻滞剂还是血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂：该先用哪个？

Cardiol Clin. 2007 Nov;25(4):581-94; vii. doi: 10.1016/j.ccl.2007.09.004.

8

Beneficial effects of carvedilol as a concomitant therapy to angiotensin-converting enzyme inhibitor in patients with ischemic left ventricular systolic dysfunction.卡维地洛作为血管紧张素转换酶抑制剂的辅助治疗对缺血性左心室收缩功能不全患者的有益作用。

Can J Physiol Pharmacol. 2007 Feb;85(2):193-9. doi: 10.1139/y07-006.

9

Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.在血管紧张素转换酶抑制剂治疗前启动卡维地洛对新诊断心力衰竭患者心脏功能的影响。

J Am Coll Cardiol. 2004 Nov 2;44(9):1825-30. doi: 10.1016/j.jacc.2004.05.087.

10

Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.血管紧张素转换酶抑制剂和β受体阻滞剂对慢性心力衰竭患者左心室重构的影响。

Minerva Cardioangiol. 2003 Apr;51(2):143-54.

引用本文的文献

1

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂用于射血分数保留的慢性心力衰竭。

Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3.

2

Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.用于射血分数保留的慢性心力衰竭的β受体阻滞剂和肾素-血管紧张素-醛固酮系统抑制剂。

Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.